Quick Comparison Table Next Steps : Consult a healthcare provider to determine which medication aligns with your needs
It could also reduce astrogliosis and microgliosis in the dentate gyrus region of the hippocampus, prevent the impairment of pro-opiomelanocortin and G-protein-coupled receptor 43 expression caused by T2D, and simultaneously increase the number of NeuN+ and GLP-1R neurons in the hippocampus [Reference de Paiva, da Silva, Mendona, de Souza and Peixoto53]
Structure/function claims These claims describe how nutrients affect the body, such as "protein helps build muscle." They avoid direct references to medications, but they can address GLP-1 users' concerns, such as loss of muscle mass
Research Highlights: Among people with both obesity and an autoimmune disease, those taking GLP-1-based medications had fewer cardiac events, fewer emergency department visits and a decreased mortality